Skip to main content

Southlake company announces funding round of roughly $50 million

The biotech firm unveils B round as it takes on cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.